NCT02544555

Brief Summary

There are two ways of approaching atherosclerotic chronic occlusive femoro-popliteal arterial lesion with guide wire. One is the intraluminal approach of passing guide wire through the atheroma, the other is the subintimal approach of passing wire through the subintima of the vessel. Either of these two interventional technique can be chosen depending on the character of the lesions they have their own pros and cons which affects the success of the intervention. The study is limited to retrospective studies to which interventional technique is better for post-procedural recurrence rate, however there is no prospective randomized controlled study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

August 27, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 9, 2015

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

September 2, 2020

Status Verified

August 1, 2020

Enrollment Period

7.1 years

First QC Date

August 27, 2015

Last Update Submit

August 31, 2020

Conditions

Keywords

Peripheral arterial diseaseAtherosclerosisIntraluminal approachSubintimal approach

Outcome Measures

Primary Outcomes (1)

  • The rate of binary restenosis.

    the rate of binary restenosis (stenosis of at least 50 percent of the luminal diameter) or PSVR ≥ 2.5 or zero (PSVR=peak systolic velocity within the area of stenosis divided by peak systolic velocity in a normal adjacent proximal artery segment) in the treated segment at 12 months after intervention as determined by catheter angiography or Duplex ultrasound.

    One year

Secondary Outcomes (13)

  • Limb salvage rate free of above-the-ankle amputation.

    One year

  • Sustained clinical improvement rate.

    One year

  • Repeated target lesion revascularization (TLR) rate.

    One year

  • Repeated target extremity revascularization (TER) rate.

    One year

  • Total reocclusion rate.

    One year

  • +8 more secondary outcomes

Study Arms (2)

Intentional intraluminal approach

EXPERIMENTAL

Intentional intraluminal approach is the way that the passage of guidewire in chronic total occlusive femoro-popliteal arterial lesion is performed via intraluminal route using various intraluminal devices. in an intraluminal approach, the response to the balloon is more favorable, but the outcome depends on the experience of the surgeon, and the approach requires more time and is more costly.

Procedure: Intentional intraluminal approach

Intentional subintimal approach

ACTIVE COMPARATOR

Intentional subintimal approach is the method that recanalization is performed via subintimal route with a 0.035-inch looped guidewire and a supporting catheter at the occlusion site. Due to its simplicity and low cost, this approach has been used for many patients with femoropopliteal occlusion.

Procedure: Intentional subintimal approach

Interventions

Interventionist performs intentional intraluminal approach to angioplasty. Dedicated 018 and 014 guidewire for Chronic Total Occlusion (CTO) lesion and Chronic Total Occlusion (CTO) devices such as Truepath or Frontrunner can be chosen by interventionist. Methods to confirm successful intraluminal wiring will be selected, as follows; 1) examination for guidewire position in different two angles on fluoroscopy or 2) intravascular ultrasound (IVUS) exam after predilation is performed with an appropriately sized angioplasty balloon. After the guidewire is passed through the lumen of target lesion, predilation of the target lesion with an optimally sized balloon will be performed prior to stent implantation. Provisional stenting should be performed, if the case that optimal ballooning response is not obtained.

Intentional intraluminal approach

Interventionist performs Intentional subintimal approach to angioplasty. 035 Terumo guidewires will be used. If 035 Terumo guidewire is not able to re-entry, Re-entry devices such as Offroad or OUTBACK catheter can be used. After the guidewire is passed through the subintimal layer of target lesion, predilation of the target lesion with an optimally sized balloon will be performed prior to stent implantation. Provisional stenting should be performed; the case that optimal ballooning response is not obtained should be enrolled. The sub-optimal balloon response is defined as a residual pressure gradient of \>15 mmHg, residual stenosis of \>30%, and flow-limiting dissection.

Intentional subintimal approach

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical Criteria
  • Age 20 years of older
  • Symptomatic peripheral-artery disease with (Rutherford 2 - 6); moderate to severe claudication (Rutherford 2-3), chronic critical limb ischemia with pain while at rest (Rutherford 4), or with ischemic ulcers (Rutherford 5-6)
  • Patients with signed informed consent
  • Anatomical Criteria
  • Chronic occlusive lesion in coronary angiography
  • Stenosis of \<50% atherosclerotic lesion of the ipsilateral femoropopliteal artery
  • Residual stenosis of \<50% atherosclerotic lesion of the ipsilateral femoro-popliteal artery after treatment for \>50% of the lesion.
  • Patent (≤50% stenosis) ipsilateral iliac artery or concomitantly treatable ipsilateral iliac lesions (≤30% residual stenosis), At least one patent (less than 50% stenosed) tibioperoneal run-off vessel.
  • Only balloon angioplasty can be performed for popliteal arterial lesion, however if suboptimal or bailout result is expected with sole balloon angioplasty, stent placement is allowed. Bailout or suboptimal result is defined as SFA lesion.

You may not qualify if:

  • Under 20 years-old or over 85 years-old.
  • Disagree with written informed consent
  • Major bleeding history within prior 2 months
  • Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, cilostazol, or contrast agent
  • Acute limb ischemia
  • Previous bypass surgery or stenting of the ipsilateral femoro-popliteal artery
  • Untreated inflow disease of the ipsilateral pelvic arteries (more than 50% stenosis or occlusion)
  • Patients with major amputation ("above the ankle" amputation) which has been done, is planned or required
  • Patients with life expectancy \<1 year due to comorbidity
  • Severe medical or surgical illness limit participating study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cardiovascular center, Korea University Guro Hospital

Seoul, 152-703, South Korea

RECRUITING

Korea University Guro Hospital

Seoul, 152-703, South Korea

RECRUITING

Seung Woon Rha

Seoul, South Korea

RECRUITING

Related Publications (15)

  • Bolia A, Miles KA, Brennan J, Bell PR. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol. 1990 Dec;13(6):357-63. doi: 10.1007/BF02578675.

    PMID: 2149672BACKGROUND
  • Noory E, Rastan A, Sixt S, Schwarzwalder U, Leppannen O, Schwarz T, Burgelin K, Hauk M, Branzan D, Hauswald K, Beschorner U, Nazary T, Brantner R, Neumann FJ, Zeller T. Arterial puncture closure using a clip device after transpopliteal retrograde approach for recanalization of the superficial femoral artery. J Endovasc Ther. 2008 Jun;15(3):310-4. doi: 10.1583/07-2324.1.

    PMID: 18540697BACKGROUND
  • Montero-Baker M, Schmidt A, Braunlich S, Ulrich M, Thieme M, Biamino G, Botsios S, Bausback Y, Scheinert D. Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther. 2008 Oct;15(5):594-604. doi: 10.1583/08-2440.1.

    PMID: 18840044BACKGROUND
  • Bosiers M, Deloose K, Callaert J, Maene L, Keirse K, Verbist J, Peeters P. In lower extremity PTAs intraluminal is better than subintimal. J Cardiovasc Surg (Torino). 2012 Apr;53(2):223-7.

    PMID: 22456645BACKGROUND
  • Soga Y, Iida O, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T. Initial and 3-year results after subintimal versus intraluminal approach for long femoropopliteal occlusion treated with a self-expandable nitinol stent. J Vasc Surg. 2013 Dec;58(6):1547-55. doi: 10.1016/j.jvs.2013.05.107. Epub 2013 Aug 1.

    PMID: 23910456BACKGROUND
  • Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010 Jun 1;3(3):267-76. doi: 10.1161/CIRCINTERVENTIONS.109.903468. Epub 2010 May 18.

    PMID: 20484101BACKGROUND
  • Strecker EP, Boos IB, Gottmann D, Vetter S, Haase W. Popliteal artery stenting using flexible tantalum stents. Cardiovasc Intervent Radiol. 2001 May-Jun;24(3):168-75. doi: 10.1007/s002700002526.

    PMID: 11443404BACKGROUND
  • Chang IS, Chee HK, Park SW, Yun IJ, Hwang JJ, Lee SA, Kim JS, Chang SH, Jung HG. The primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patients. Korean J Radiol. 2011 Mar-Apr;12(2):203-9. doi: 10.3348/kjr.2011.12.2.203. Epub 2011 Mar 3.

    PMID: 21430937BACKGROUND
  • Kidd J, Bourke BM, Dunwoodie J et al. The role of pre and postprocedural color Duplex ultrasound for the treatment of lower limb ischemia by subintimal angioplasty. J Vasc Ultrasound. 2006;30:17-21.

    BACKGROUND
  • Lipsitz EC, Ohki T, Veith FJ, Suggs WD, Wain RA, Cynamon J, Mehta M, Cayne N, Gargiulo N. Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg. 2003 Feb;37(2):386-91. doi: 10.1067/mva.2003.20.

    PMID: 12563211BACKGROUND
  • London NJ, Srinivasan R, Naylor AR, Hartshorne T, Ratliff DA, Bell PR, Bolia A. Reprinted article "Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results". Eur J Vasc Endovasc Surg. 2011 Sep;42 Suppl 1:S9-15. doi: 10.1016/j.ejvs.2011.06.018.

    PMID: 21855032BACKGROUND
  • Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997 Sep;26(3):517-38. doi: 10.1016/s0741-5214(97)70045-4.

    PMID: 9308598BACKGROUND
  • Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, Diehm C, Biamino G, Vermassen F, Scheinert D, van Sambeek MR, Schillinger M. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J. 2007 Apr;28(7):798-805. doi: 10.1093/eurheartj/ehl545. Epub 2007 Feb 22.

    PMID: 17317699BACKGROUND
  • Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Beregi JP. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002 Sep 17;106(12):1505-9. doi: 10.1161/01.cir.0000029746.10018.36.

    PMID: 12234956BACKGROUND
  • Vollmar J (1975) Rekonstruktive Chirurgie der Arterien. Georg Thieme Verlag, Stuttgart, pp 265-266.

    BACKGROUND

MeSH Terms

Conditions

Peripheral Arterial DiseaseAtherosclerosis

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Study Officials

  • Seung-Woon Rha, MD, PhD

    Cardiovascular Center, Korea University Guro Hospital, 80, Guro-dong, Guro-gu, Seoul, 152-703, South Korea

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seung-Woon Rha, MD, PhD

CONTACT

Sang-Ho Park, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

August 27, 2015

First Posted

September 9, 2015

Study Start

May 1, 2014

Primary Completion

May 31, 2021

Study Completion

May 31, 2022

Last Updated

September 2, 2020

Record last verified: 2020-08

Locations